MISSLING CHRISTOPHER U bought AVXL
January 6, 2026 · Form 4 insider transaction
MISSLING CHRISTOPHER U bought 125,000 shares of Anavex Life Sciences Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
$0.00
Total value
N/A
InsiderMISSLING CHRISTOPHER U
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2026
Filing dateJanuary 9, 2026
Shares owned after125,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 31, 2025, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was a Second Regulatory dialogue for blarcamesine. The performance criteria for this milestone was met, resulting in vesting of the option as to 125,000 shares.